Moonwalk Biosciences

About Moonwalk Biosciences

Moonwalk Biosciences is pioneering novel therapeutics in adipose biology and tissue, driven by deep genetic and epigenetic insights. Their mission focuses on advancing medical solutions through innovative approaches in biology.

Products & Services

Novel Therapeutics:Focused on adipose biology and tissue, leveraging genetic and epigenetic insights to develop innovative treatments.

Multiplex Epigenetic Engineering Platform:A platform for epigenetic editing, presented at ASGCT 2024, aimed at advancing therapeutic development.

Specialties

Adipose Biology Epigenetic Engineering Genetic Insights Cardiometabolic Research RNA and Molecular Biology Bioinformatics and ML/AI Immunology Research Delivery Sciences

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed and Series A T: - FT: Seed and Series A	A: 57000000 MR: - FA: $57 million FAN: 57000000	D: 2024-01-04 FD: 2024-01-04	6 investors

Seed and Series A Latest

2024-01-04

$57.0M

6 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Rohit Loomba

Professor of Medicine and Chief, Division of Gastroenterology and Hepatology

S

Shingo Kajimura

Professor, Harvard Medical School

LinkedIn (Pro only)

M

Michael Czech

Isadore and Fannie Foxman Chair of Medical Research

S

Silvia Corvera

Endowed Chair in Diabetes Research and Professor in Molecular Medicine

P

Paul Cohen

Associate Professor, Rockefeller University

P

Paul Cohen, MD, PhD

Associate Professor, Rockefeller University

View 47 more team members with Pro

Unlock Full Team Directory

Recent News